286 related articles for article (PubMed ID: 21406394)
1. MYC and metastasis.
Wolfer A; Ramaswamy S
Cancer Res; 2011 Mar; 71(6):2034-7. PubMed ID: 21406394
[TBL] [Abstract][Full Text] [Related]
2. MYC regulation of a "poor-prognosis" metastatic cancer cell state.
Wolfer A; Wittner BS; Irimia D; Flavin RJ; Lupien M; Gunawardane RN; Meyer CA; Lightcap ES; Tamayo P; Mesirov JP; Liu XS; Shioda T; Toner M; Loda M; Brown M; Brugge JS; Ramaswamy S
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3698-703. PubMed ID: 20133671
[TBL] [Abstract][Full Text] [Related]
3. Prognostic signatures, cancer metastasis and MYC.
Wolfer A; Ramaswamy S
Cell Cycle; 2010 Sep; 9(18):3639. PubMed ID: 20930551
[No Abstract] [Full Text] [Related]
4. Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.
Elkon R; Loayza-Puch F; Korkmaz G; Lopes R; van Breugel PC; Bleijerveld OB; Altelaar AF; Wolf E; Lorenzin F; Eilers M; Agami R
EMBO Rep; 2015 Dec; 16(12):1723-36. PubMed ID: 26538417
[TBL] [Abstract][Full Text] [Related]
5. MYC and the control of DNA replication.
Dominguez-Sola D; Gautier J
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890833
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
7. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits.
Liu H; Radisky DC; Yang D; Xu R; Radisky ES; Bissell MJ; Bishop JM
Nat Cell Biol; 2012 May; 14(6):567-74. PubMed ID: 22581054
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between oncogenic MYC and noncoding RNAs in cancer.
Tu R; Chen Z; Bao Q; Liu H; Qing G
Semin Cancer Biol; 2021 Oct; 75():62-71. PubMed ID: 33160022
[TBL] [Abstract][Full Text] [Related]
9. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
[TBL] [Abstract][Full Text] [Related]
10. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
12. MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer.
Schulze A; Oshi M; Endo I; Takabe K
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143224
[No Abstract] [Full Text] [Related]
13. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2.
Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP38 promotes cell proliferation through stabilizing c-Myc.
Xu Z; Hu H; Fang D; Wang J; Zhao K
Int J Biochem Cell Biol; 2021 Aug; 137():106023. PubMed ID: 34102342
[TBL] [Abstract][Full Text] [Related]
16. A noncoding RNA LINC00504 interacts with c-Myc to regulate tumor metabolism in colon cancer.
Feng J; Ma J; Liu S; Wang J; Chen Y
J Cell Biochem; 2019 Sep; 120(9):14725-14734. PubMed ID: 30998289
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
Aravalli RN; Talbot NC; Steer CJ
World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
[TBL] [Abstract][Full Text] [Related]
19. YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.
Leal MF; Ribeiro HF; Rey JA; Pinto GR; Smith MC; Moreira-Nunes CA; Assumpção PP; Lamarão LM; Calcagno DQ; Montenegro RC; Burbano RR
Oncotarget; 2016 Dec; 7(51):85393-85410. PubMed ID: 27863420
[TBL] [Abstract][Full Text] [Related]
20. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
